Core Scientific, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M | $8.7M |
| Accounts Receivable | — | $1.0M | $1.0M | $234.0K | $1.4M | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $895.5M | $904.0M | $97.0M | $85.1M | $756.6M | — |
| Property, Plant & Equipment | $1.29B | $433.5M | — | — | — | — |
| Goodwill | — | — | $0 | $0 | $1.06B | — |
| Intangible Assets (Excl. Goodwill) | — | — | $2.2M | $1.7M | $8.2M | — |
| Total Assets | $2.35B | $1.48B | $712.2M | $807.7M | $2.44B | $15.0K |
| Liabilities | ||||||
| Accounts Payable | $126.1M | $19.3M | $154.8M | $53.6M | $11.6M | — |
| Total Current Liabilities | $781.4M | $134.6M | $488.4M | $186.8M | $320.3M | $400 |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.05B | $400 |
| Stockholders' Equity | ||||||
| Retained Earnings | $-4.15B | $-3.86B | $-2.42B | $-2.17B | $-27.4M | $-10.4K |
| Total Stockholders' Equity | $-962.7M | $-943.0M | $-596.9M | $-409.3M | $1.34B | $89.2M |